Paper Details

  1. Home
  2. Paper Details

Ondansetron versus dolasetron: a comparison study in the prevention of postoperative nausea and vomiting in patients undergoing gynecological procedures.

Author: BrowningBeth A, FortCarol A, KempKevan D, ShimataManardie F, StrubeMelissa D

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study compared the effectiveness of 4 mg ondansetron and 12.5 mg dolasetron for preventing postoperative nausea and vomiting (PONV) in patients undergoing gynecological procedures. The study found no statistically significant difference in the effectiveness of these two antiemetics.
Paper Details　
Original Abstract of the Article :
The purpose of this study was to determine if 4 mg of ondansetron and 12.5 mg of dolasetron were equally effective in preventing postoperative nausea and vomiting (PONV) in patients undergoing gynecological procedures. While the overall incidence of PONV appears to be 25% to 35%, the incidence among...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/15098526

データ提供：米国国立医学図書館（NLM）

Ondansetron vs. Dolasetron: A Battle for Relief from Postoperative Nausea

Postoperative nausea and vomiting (PONV) is a common and unwelcome companion for many patients after surgery. Finding the right antiemetic medication to prevent PONV can feel like searching for a hidden spring in the desert of recovery. This study compares the effectiveness of two antiemetic drugs, ondansetron and dolasetron, in preventing PONV in patients undergoing gynecological procedures. It's like a duel between two warriors, each vying for the title of 'most effective' in the fight against postoperative nausea.

A Tie in the Duel: Ondansetron and Dolasetron Equal in Effectiveness

The study found no statistically significant difference in the effectiveness of ondansetron and dolasetron in preventing PONV. Both medications were equally effective in reducing the incidence of nausea and vomiting after surgery. It's like a tie in the duel, with both warriors proving their worth in the fight against postoperative nausea.

Navigating the Desert of Postoperative Nausea: Finding the Right Solution

If you're facing surgery, talk to your doctor about your risk factors for PONV and discuss the available antiemetic options. While this study suggests that ondansetron and dolasetron are equally effective, the best choice for you will depend on your individual needs and preferences. There are many ways to combat postoperative nausea, and finding the right solution can make a world of difference in your recovery.

Dr. Camel's Conclusion

This study provides valuable insights into the effectiveness of ondansetron and dolasetron in preventing postoperative nausea and vomiting. The findings suggest that both medications are equally effective, offering patients a choice based on factors like cost and individual preferences. This study serves as a reminder that the journey through postoperative recovery is often smoother when equipped with the right tools and knowledge.

Date :
  1. Date Completed 2004-06-01
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

15098526

DOI: Digital Object Identifier

15098526

Related Literature

Article Analysis
・Side Effects of dolasetron
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.